RedHill Biopharma (RDHL) Short Interest Ratio & Short Volume $7.29 +0.30 (+4.29%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends RedHill Biopharma Short Interest DataRedHill Biopharma (RDHL) has a short interest of 1,600 shares, representing 0.13% of the float (the number of shares available for trading by the public). This marks a -78.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 14,476 shares to cover all short positions.Current Short Interest1,600 sharesPrevious Short Interest7,400 sharesChange Vs. Previous Month-78.38%Dollar Volume Sold Short$13,184.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,270,000 sharesFloat Size1,270,000 sharesShort Percent of Float0.13%Today's Trading Volume11,707 sharesAverage Trading Volume14,476 sharesToday's Volume Vs. Average81% Short Selling RedHill Biopharma? Sign up to receive the latest short interest report for RedHill Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRDHL Short Interest Over TimeRDHL Days to Cover Over TimeRDHL Percentage of Float Shorted Over Time Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t RedHill Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20241,600 shares $13,184.00 -78.4%0.1%0 $8.24 10/15/20247,400 shares $59,940.00 -73.5%0.6%0 $8.10 9/30/202427,900 shares $243,846.00 -44.0%2.2%0.1 $8.74 9/15/202449,800 shares $548,298.00 -58.7%3.9%0.2 $11.01 8/31/2024120,500 shares $1.02 million +455.3%9.5%0.4 $8.50 8/15/202421,700 shares $5.09 million -94.8%1.7%0.1 $234.38 Get the Latest News and Ratings for RDHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RedHill Biopharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024417,400 shares $160,323.34 +23.1%1.3%0.1 $0.38 7/15/2024339,200 shares $135,917.44 -31.0%1.1%1.3 $0.40 6/30/2024491,400 shares $182,161.98 -4.3%1.6%1.7 $0.37 6/15/2024513,700 shares $199,932.55 -7.6%1.6%1.6 $0.39 5/31/2024556,000 shares $254,703.60 -14.5%1.8%1.5 $0.46 5/15/2024650,200 shares $299,092.00 -13.7%2.1%1.4 $0.46 4/30/2024753,600 shares $325,027.68 +1.6%2.4%1.5 $0.43 4/15/2024741,500 shares $299,640.15 -18.2%2.5%0.6 $0.40 3/31/2024906,900 shares $480,566.31 -14.4%3.1%0.7 $0.53 3/15/20241,060,000 shares $558,408.00 +181.8%3.6%0.8 $0.53 2/29/2024376,200 shares $231,363.00 -38.9%1.3%0.2 $0.62 2/15/2024615,700 shares $334,756.09 -44.5%2.1%0.1 $0.54 1/31/20241,110,000 shares $643,800.00 +263.1%3.8%0.1 $0.58 1/15/2024305,700 shares $324,042.00 -57.5%1.6%0 $1.06 12/31/2023720,000 shares $1.05 million +149.3%3.7%0.1 $1.46 12/15/2023288,800 shares $329,232.00 -93.9%1.5%0 $1.14 11/30/20234,740,000 shares $9.48 million +16,188.7%24.2%0.5 $2.00 11/15/202329,100 shares $9,748.50 -90.1%0.3%0 $0.34 10/31/2023293,600 shares $129,184.00 +153.1%2.7%0.2 $0.44 10/15/2023116,000 shares $37,120.00 +590.5%1.1%0.1 $0.32 9/30/202316,800 shares $8,568.00 +200.0%0.3%0 $0.51 9/15/20235,600 shares $4,760.00 -27.3%0.1%0 $0.85 8/31/20237,700 shares $6,768.30 +102.6%0.1%0 $0.88 8/15/20233,800 shares $3,156.66 -85.7%0.1%0 $0.83 7/31/202326,600 shares $34,048.00 -77.7%0.5%0.1 $1.28 7/15/2023119,400 shares $213,726.00 +594.2%4.1%0.6 $1.79 6/30/202317,200 shares $20,640.00 -39.0%0.6%0.1 $1.20 6/15/202328,200 shares $54,990.00 -64.5%1.0%0.3 $1.95 5/31/202379,400 shares $184,208.00 -31.9%2.7%0.8 $2.32 5/15/2023116,600 shares $267,014.00 -31.7%4.0%1.2 $2.29 4/30/2023170,700 shares $414,801.00 +9.4%6.4%1.6 $2.43 4/15/2023156,100 shares $501,081.00 +25.6%5.8%1 $3.21 3/31/2023124,300 shares $508,387.00 -11.7%5.1%0.8 $4.09 3/15/2023140,800 shares $1.01 million -97.8%N/A0.9 $7.16Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide 2/28/20236,410,000 shares $1.45 million -3.0%N/A1.1 $0.23 2/15/20236,610,000 shares $1.41 million -18.5%N/A1.1 $0.21 1/31/20238,110,000 shares $1.77 million +279.0%N/A1.4 $0.22 1/15/20232,140,000 shares $422,650.00 +22.3%N/A0.7 $0.20 12/30/20221,750,000 shares $245,525.00 +32.6%N/A0.4 $0.14 12/15/20221,320,000 shares $252,120.00 -47.6%N/A0.4 $0.19 11/30/20222,520,000 shares $907,200.00 +22.3%N/A0.8 $0.36 11/15/20222,060,000 shares $1.13 million -14.9%N/A0.7 $0.55 10/31/20222,420,000 shares $1.68 million -8.0%N/A0.9 $0.70 10/15/20222,630,000 shares $1.36 million -1.1%N/A0.9 $0.52 9/30/20222,660,000 shares $1.34 million +60.2%N/A1.8 $0.50 9/15/20221,660,000 shares $1.32 million No ChangeN/A0.7 $0.80 8/31/20221,660,000 shares $1.49 million +4.4%N/A0.5 $0.90 8/15/20221,590,000 shares $1.65 million -7.6%N/A0.5 $1.04 7/31/20221,720,000 shares $1.50 million -16.9%N/A0.6 $0.87 7/15/20222,070,000 shares $1.97 million -25.0%N/A0.8 $0.95 6/30/20222,760,000 shares $2.40 million +117.3%N/A1.1 $0.87 6/15/20221,270,000 shares $814,832.00 -17.0%N/A0.7 $0.64 5/31/20221,530,000 shares $1.71 million -5.6%N/A3.8 $1.12 5/15/20221,620,000 shares $1.65 million +2.5%N/A3.9 $1.02 4/30/20221,580,000 shares $2.67 million +7.5%N/A3.9 $1.69 4/15/20221,470,000 shares $2.97 million -3.3%N/A3.7 $2.02 3/31/20221,520,000 shares $3.83 million +3.4%N/A3.4 $2.52 3/15/20221,470,000 shares $2.43 million +5.0%N/A3.1 $1.65 2/28/20221,400,000 shares $3.07 million +1.5%N/A2.6 $2.19 2/15/20221,380,000 shares $3.45 million -14.8%N/A2.2 $2.50 1/31/20221,620,000 shares $4.26 million +26.6%N/A2.2 $2.63 1/15/20221,280,000 shares $3.16 million -23.8%N/A1.7 $2.47 12/31/20211,680,000 shares $4.33 million -17.7%N/A2.1 $2.58 12/15/20212,040,000 shares $5.73 million +10.3%N/A2.1 $2.81 11/30/20211,850,000 shares $5.40 million -21.6%N/A1.7 $2.92 11/15/20212,360,000 shares $10.71 million -14.2%5.1%1.9 $4.54 10/29/20212,750,000 shares $14.96 million +10.9%6.0%2.5 $5.44 10/15/20212,480,000 shares $12.13 million +90.8%5.4%2.3 $4.89 9/30/20211,300,000 shares $5.95 million No Change2.8%1.3 $4.58 9/15/20211,300,000 shares $6.32 million -29.7%2.8%1.6 $4.86 8/31/20211,850,000 shares $18.69 million -8.9%4.0%3.1 $10.10 8/13/20212,030,000 shares $14.41 million +21.6%4.4%6.7 $7.10 7/30/20211,670,000 shares $10.75 million -19.3%3.7%5.8 $6.44 7/15/20212,070,000 shares $12.36 million +10.1%N/A7.6 $5.97 6/30/20211,880,000 shares $12.93 million +2.7%N/A7.4 $6.88 6/15/20211,830,000 shares $13.12 million -7.6%N/A6.8 $7.17 5/28/20211,980,000 shares $14.36 million -14.7%N/A6.9 $7.25 5/14/20212,320,000 shares $13.87 million +17.8%N/A6.8 $5.98 4/30/20211,970,000 shares $13.73 million -2.0%N/A4.8 $6.97 4/15/20212,010,000 shares $14.23 million -27.2%N/A3.7 $7.08 3/31/20212,760,000 shares $19.73 million +8.7%N/A4.7 $7.15 3/15/20212,540,000 shares $20.07 million +5.4%N/A4.3 $7.90 2/26/20212,410,000 shares $23.96 million No ChangeN/A4.2 $9.94 2/12/20212,410,000 shares $22.75 million -5.9%N/A4.8 $9.44Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide 1/29/20212,560,000 shares $22.58 million +8.9%N/A5.7 $8.82 1/15/20212,350,000 shares $17.32 million -2.5%N/A5.9 $7.37 12/31/20202,410,000 shares $20.63 million +23.6%N/A7.6 $8.56 12/15/20201,950,000 shares $16.58 million +2.1%N/A7.3 $8.50 11/30/20201,910,000 shares $16.90 million +21.7%N/A6.1 $8.85 11/15/20201,570,000 shares $12.86 million -11.8%N/A4.7 $8.19 10/30/20201,780,000 shares $15.56 million +8.5%N/A5.4 $8.74 10/15/20201,640,000 shares $16.53 million +3.1%N/A4.1 $10.08 9/30/20201,590,000 shares $16.25 million -20.5%N/A4 $10.22 9/15/20202,000,000 shares $21.52 million +1.0%59.9%4.7 $10.76 8/31/20201,980,000 shares $16.35 million -4.4%59.3%5 $8.26 8/14/20202,070,000 shares $16.10 million -2.4%N/A5.7 $7.78 7/31/20202,120,000 shares $16.81 million +5.0%N/A6 $7.93 7/15/20202,020,000 shares $12.89 million +12.2%N/A5.3 $6.38 6/30/20201,800,000 shares $12.64 million +7.8%N/A4 $7.02 6/15/20201,670,000 shares $11.57 million -2.3%N/A3.7 $6.93 5/29/20201,710,000 shares $11.88 million +1.8%N/A3.8 $6.95 5/15/20201,680,000 shares $11.29 million +5.0%N/A3.6 $6.72 4/30/20201,600,000 shares $11.49 million +31.2%N/A3.6 $7.18 4/15/20201,220,000 shares $9.10 million No ChangeN/A3.3 $7.46 3/31/20201,220,000 shares $9.27 million -15.9%N/A4.4 $7.60 3/13/20201,451,100 shares $8.78 million -1.3%N/A6.3 $6.05 2/28/20201,470,000 shares $6.20 million +0.7%N/A7.3 $4.22 2/14/20201,460,000 shares $6.35 million +12.3%N/A7.1 $4.35 1/31/20201,300,000 shares $6.10 million +2.4%N/A6 $4.69 1/15/20201,270,000 shares $6.32 million +5.8%N/A4.1 $4.98 12/31/20191,200,000 shares $7.15 million -7.7%N/A4.1 $5.96 RDHL Short Interest - Frequently Asked Questions What is RedHill Biopharma's current short interest? Short interest is the volume of RedHill Biopharma shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 1,600 shares of RDHL short. 0.13% of RedHill Biopharma's shares are currently sold short. Learn More on RedHill Biopharma's current short interest. What is a good short interest percentage for RedHill Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of RedHill Biopharma's floating shares are currently sold short. Is RedHill Biopharma's short interest increasing or decreasing? RedHill Biopharma saw a decrease in short interest in October. As of October 31st, there was short interest totaling 1,600 shares, a decrease of 78.4% from the previous total of 7,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is RedHill Biopharma's float size? RedHill Biopharma currently has issued a total of 1,270,000 shares. Some of RedHill Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RedHill Biopharma currently has a public float of 1,270,000 shares. How does RedHill Biopharma's short interest compare to its competitors? 0.13% of RedHill Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to RedHill Biopharma: MEI Pharma, Inc. (1.23%), OKYO Pharma Limited (1.11%), Lexaria Bioscience Corp. (1.72%), Clene Inc. (2.91%), Lumos Pharma, Inc. (1.54%), BioLineRx Ltd. (1.33%), Iterum Therapeutics plc (11.53%), Dyadic International, Inc. (0.87%), Marker Therapeutics, Inc. (1.09%), Longeveron Inc. (28.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short RedHill Biopharma stock? Short selling RDHL is an investing strategy that aims to generate trading profit from RedHill Biopharma as its price is falling. RDHL shares are trading up $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RedHill Biopharma? A short squeeze for RedHill Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RDHL, which in turn drives the price of the stock up even further. How often is RedHill Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDHL, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies MEI Pharma Short Interest Data OKYO Pharma Short Interest Data Lexaria Bioscience Short Interest Data Clene Short Interest Data Lumos Pharma Short Interest Data BioLineRx Short Interest Data Iterum Therapeutics Short Interest Data Dyadic International Short Interest Data Marker Therapeutics Short Interest Data Longeveron Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RDHL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share RedHill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
